ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 72 filers reported holding ANTHERA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $83,000 | -46.5% | 26,383 | -47.2% | 0.00% | -100.0% |
Q2 2016 | $155,000 | -19.3% | 50,000 | -50.0% | 0.00% | 0.0% |
Q3 2014 | $192,000 | +12.9% | 100,000 | +100.0% | 0.00% | 0.0% |
Q2 2014 | $170,000 | +1.2% | 50,000 | 0.0% | 0.00% | -50.0% |
Q1 2014 | $168,000 | -45.3% | 50,000 | -50.0% | 0.00% | 0.0% |
Q4 2013 | $307,000 | -23.6% | 100,000 | 0.0% | 0.00% | -50.0% |
Q3 2013 | $402,000 | – | 100,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 1,250,000 | $1,975,000 | 1.00% |
Broadfin Capital, LLC | 3,567,624 | $5,636,000 | 0.24% |
Abingworth LLP | 437,994 | $679,000 | 0.19% |
GREAT POINT PARTNERS LLC | 250,000 | $395,000 | 0.19% |
Rhenman & Partners Asset Management AB | 400,000 | $632,000 | 0.18% |
BVF INC/IL | 559,624 | $884,000 | 0.17% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,691,857 | $2,673,000 | 0.10% |
Perceptive Advisors | 503,156 | $795,000 | 0.07% |
Gruss Capital Management LP | 960,000 | $1,517,000 | 0.04% |
Spark Investment Management LLC | 103,400 | $160,000 | 0.03% |